Bristol Myers Squibb is shedding two clinical programs, one from its 2023 Mirati buyout and another from a partnership with U ...
Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare ...
During BMS’ earnings call Thursday, CEO Chris Boerner, Ph.D., described Cobenfy as “delivering steady growth.” But the first-in-class drug still has a long way to go to fulfill its promise as a ...
DISP-10 is a novel tumor-specific virus and CAR T combination designed to overcome key challenges of applying CAR T therapy to solid tumors DISP-10 has broad potential to target all solid tumors of ...
Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec Biologics ("JEB"; +11.3%) above-expectation; further accelerating growth on non-Sandoz / non-DOD ...
Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...
Bristol Myers Squibb showcases new long-term and real-world data from cardiovascular portfolio at the AHA scientific sessions 2025: Princeton, New Jersey Wednesday, November 5, 20 ...
The markets in Everett and Revere offer plates of fresh Oaxacan food, shelves full of Mexican staples, a bakery, and a ...
The event brought together the BHS chorus, BHS drama, BHS art, and the BMS chorus at the high school’s Performing Arts Center ...
Fulop is taking a high-paying job at Partnership for New York City after he wraps up his time as mayor. He doesn’t have much ...
(Batesville, IN) – Batesville Middle School will host its annual Veterans Day Program on Tuesday, November 11 at 9 a.m. in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback